NCT03725306View on ClinicalTrials.gov

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss

PHASE3UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

September 1, 2022

Study Completion Date

December 1, 2022

Conditions
MenorrhagiaHeavy Menstrual Bleeding
Interventions
DEVICE

Librata

Hyperthermic endomyometrial treatment via Librata catheter and balloon device

Sponsors

Lead Sponsor

LiNA Medical
All Listed Sponsors
collaborator

Syntactx

NETWORK

collaborator

West Virginia University, Pathology Laboratory for Translational Medicine

UNKNOWN

collaborator

Infinite Clinical Research, S.A. de C.V.

INDUSTRY

lead

LiNA Medical

INDUSTRY